Showing results (291-300 of 347) with videos related to

Sort By:
Pageof 35
Clinical Journal of the American Society of Nephrology : CJASN|August 11, 2017
Association of QT-Prolonging Medication Use in CKD with Electrocardiographic ManifestationsSoren Snitker, Rebecca M Doerfler, Elsayed Z Soliman, et al.
Kidney International|July 3, 2016
Abnormalities in biomarkers of mineral and bone metabolism in kidney donorsBertram L Kasiske, Rajiv Kumar, Paul L Kimmel, et al.
Hypertension (Dallas, Tex. : 1979)|December 30, 2015
Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort StudyGeorge Thomas, Dawei Xie, Hsiang-Yu Chen, et al.
Kidney Medicine|April 4, 2022
Emergency Department/Urgent Care as Usual Source of Care and Clinical Outcomes in CKD: Findings From the Chronic Renal Insufficiency Cohort StudyStephanie M Toth-Manikowski, Jesse Y Hsu, Michael J Fischer, et al.
The New England Journal of Medicine|April 23, 2025
Lorundrostat Efficacy and Safety in Patients with Uncontrolled HypertensionLuke J Laffin, Branko Kopjar, Carrie Melgaard, et al.
Hypertension (Dallas, Tex. : 1979)|February 20, 2019
Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney DiseaseJing Chen, Joshua D Bundy, L Lee Hamm, et al.
American Journal of Nephrology|October 19, 2012
Urinary sodium is a potent correlate of proteinuria: lessons from the chronic renal insufficiency cohort studyMatthew R Weir, Raymond R Townsend, Jeffrey C Fink, et al.
American Heart Journal|October 31, 2006
Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes--the Stop Atherosclerosis in Native Diabetics Study (SANDS)Marie Russell, Jerome L Fleg, Wm James Galloway, et al.
Digestive Diseases and Sciences|February 3, 2018
Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with CirrhosisAyse L Mindikoglu, Antone R Opekun, William E Mitch, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 13, 2009
Safety and feasibility of achieving lower systolic blood pressure goals in persons with type 2 diabetes: the SANDS trialMatthew R Weir, Fawn Yeh, Angela Silverman, et al.
Pageof 35